The Top 10 Contract Research Organizations
Date Published:
March 16, 2009 Price:
3,835.00 Source:
Business Insights Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe. Clinical obstacles to approval have become more significant due to the growing availability of existing generic treatments, and the trend to adopt Health Economics Outcomes Research (HEOR) assessments is increasing the complexity of clinical research. As a result, the scope of the CRO industry is expanding, and the global market is predicted to value $35bn by 2013. Click here to read more.
More Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
- Seasonal Influenza Vaccines Market Forecast
- Generics Series: Authorized Generics Analysis
- Pricing and Reimbursement: Innovative Risk-Sharing Strategies
- Emerging Markets Series: The Pharmaceutical Market of Poland
